Pasithea Therapeutics (KTTA) Liabilities from Discontinued Operations (2022 - 2023)
Pasithea Therapeutics (KTTA) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 299669.0 as the latest value for Q1 2023.
- Quarterly Liabilities from Discontinued Operations changed N/A to 299669.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was 299669.0 through Mar 2023, changed N/A year-over-year, with the annual reading at 319575.0 for FY2022, N/A changed from the prior year.
- Liabilities from Discontinued Operations hit 299669.0 in Q1 2023 for Pasithea Therapeutics, down from 319575.0 in the prior quarter.
- In the past five years, Liabilities from Discontinued Operations ranged from a high of 319575.0 in Q4 2022 to a low of 299669.0 in Q1 2023.